Search Login Register

Melphalan (Alkeran) Summary

Description: An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.

Also Known As: Alkeran; L-PAM; Sarcolysine; 4-(Bis(2-chloroethyl)amino)phenylalanine; Mustard, Phenylalanine Show All >>

Networked: 3245 relevant articles (391 outcomes, 582 trials/studies) for this Drug

Key Diseases for which Melphalan is Relevant

  1. Multiple Myeloma : 82 outcomes 199 studies in 811 results
  2. Neoplasms (Cancer) : 62 outcomes 79 studies in 645 results
  3. Melanoma (Melanoma, Malignant) : 33 outcomes 55 studies in 324 results
  4. Amyloidosis : 31 outcomes 23 studies in 176 results
  5. Sarcoma (Soft Tissue Sarcoma) : 22 outcomes 19 studies in 156 results
Show All >>

Drugs Related to Melphalan

  1. Prednisone (Sone)
  2. Dexamethasone (Maxidex)
  3. Cyclophosphamide (Cytoxan)
  4. Etoposide (VP 16)
  5. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  6. Melphalan (Alkeran)
  7. Prednisolone (Predate)
  8. Doxorubicin (Adriamycin)
  9. Vincristine (Oncovin)
  10. bortezomib (Velcade)
Show All >>

Therapies Related to Melphalan

  1. Drug Therapy (Chemotherapy)
  2. Stem Cell Transplantation
  3. Transplants (Transplant)
  4. Combination Drug Therapy (Combination Chemotherapy)
  5. Bone Marrow Transplantation (Transplantation, Bone Marrow)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.